MYCN and neoplasm: A number of clinical features and tumor phenotypes influence the disease outcome; the most important are age at diagnosis, tumor stage, amplification of the MYCN oncogene, activating ALK mutations, and somatic loss within chromosomal region 1p[1,2,4-8].